[In the Media] Antimicrobial Resistance (AMR) Awareness Month – The Issue of Antimicrobial Resistance, The Promotion of Drug Discovery and Stable Supply (Medical Tribune, November 10, 2022)
date : 12/5/2022
Tags: AMR
![[In the Media] Antimicrobial Resistance (AMR) Awareness Month – The Issue of Antimicrobial Resistance, The Promotion of Drug Discovery and Stable Supply (Medical Tribune, November 10, 2022)](https://hgpi.xsrv.jp/en/wp-content/uploads/sites/2/AMRalliance-logo-11-27.jpg){kind=logo}
Health and Global Policy Institute (HGPI) has been tackling the issue of Antimicrobial Resistance (AMR) since 2016 and serves as the secretariat of AMR Alliance Japan.
On November 10, 2022, the Medical Tribune featured a media forum held on November 8 by the International Committee of the Japan Pharmaceutical Manufacturers Association (JPMA) in cooperation with the AMR Alliance Japan, entitled “Toward Antimicrobial Resistance (AMR) Awareness Month.”
For more details, please refer here.
*Available only in Japanese
**The full article can be read after logging in.
Top Research & Recommendations Posts
- [Joint Report and Recommendations] “Rebalancing Health System: Innovation and Sustainability” A Joint Global Expert Meeting convened by the CSIS and HGPI
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [Research Report] 2017 Public Survey on Healthcare in Japan
- [Research Report] Public Opinion Survery on the Threat of Antimicrobial Resistance (AMR) (November 26, 2021)
